Opinion: Congress Must Make Affordable, Life-Saving ‘Biosimilar’ Drugs a Priority

Many California patients and their families struggle to afford their life-saving and life-sustaining health care. This is particularly true for those living with chronic and life-threatening conditions such as liver disease, cancer, hepatitis, arthritis, multiple sclerosis, and others for which the cost of treatment can be prohibitive. Biosimilar medications hold the potential to increase access […]